The Food and Drug Administration granted approval of the drug, Zurzuvae, for adults experiencing severe depression related to childbirth or pregnancy. The pill is taken once a day for 14 days.
(Image credit: LM Otero/AP)
The FDA approves the first pill specifically intended to treat postpartum depression
Comment